Felicia Wilson

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease

British Journal of Haematology · 2007 · 223 citations

Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease

British Journal of Haematology · 2011 · 61 citations